EP1208101 - VITRONECTIN RECEPTOR ANTAGONISTS USEFUL FOR THE TREATMENT OF STROKES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.09.2003 Database last updated on 31.08.2024 | Most recent event Tooltip | 05.09.2003 | Application deemed to be withdrawn | published on 22.10.2003 [2003/43] | Applicant(s) | For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia, PA 19103 / US | [N/P] |
Former [2002/22] | For all designated states SmithKline Beecham Corporation One Franklin Plaza Philadelphia, PA 19103 / US | Inventor(s) | 01 /
BARONE, Frank, C. 2861 Eagleville Road Audubon, PA 19403 / US | 02 /
YUE, Tian-Li 308 Earlington Road Havertown, PA 19083 / US | [2002/22] | Representative(s) | Valentine, Jill Barbara, et al GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
Former [2002/22] | Valentine, Jill Barbara, et al GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 00952558.5 | 04.08.2000 | [2002/22] | WO2000US21433 | Priority number, date | US19990147567P | 06.08.1999 Original published format: US 147567 P | [2002/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0110867 | Date: | 15.02.2001 | Language: | EN | [2001/07] | Type: | A1 Application with search report | No.: | EP1208101 | Date: | 29.05.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.02.2001 takes the place of the publication of the European patent application. | [2002/22] | Search report(s) | International search report - published on: | US | 15.02.2001 | (Supplementary) European search report - dispatched on: | EP | 30.01.2003 | Classification | IPC: | C07D487/00, C07D401/12, C07D413/12, C07D417/12, A61K31/44, A61K31/47, A61P9/00 | [2003/12] | CPC: |
A61K31/55 (EP);
A61P17/02 (EP);
A61P25/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP)
|
Former IPC [2002/22] | C07D487/00, C07D401/12, C07D413/12, C07D417/12, A61K31/44, A61K31/47 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/22] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | ZUR BEHANDLUNG VON SCHLAGANFÄLLEN NÜTZLICHE VITRONEKTIN-REZEPTOR-ANTAGONISTEN | [2002/22] | English: | VITRONECTIN RECEPTOR ANTAGONISTS USEFUL FOR THE TREATMENT OF STROKES | [2002/22] | French: | ANTAGONISTES DU RECEPTEUR DE LA VITRONECTINE UTILES POUR LE TRAITEMENT DES ACCIDENTS VASCULAIRES CEREBRAUX | [2002/22] | Entry into regional phase | 15.02.2002 | National basic fee paid | 15.02.2002 | Search fee paid | 15.02.2002 | Designation fee(s) paid | 15.02.2002 | Examination fee paid | Examination procedure | 20.02.2001 | Request for preliminary examination filed International Preliminary Examining Authority: US | 15.02.2002 | Amendment by applicant (claims and/or description) | 15.02.2002 | Examination requested [2002/22] | 16.04.2003 | Application deemed to be withdrawn, date of legal effect [2003/43] | 21.05.2003 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2003/43] | Fees paid | Renewal fee | 07.08.2002 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XD]WO9814192 (SMITHKLINE BEECHAM CORP [US], et al) [XD] 1-5 * see claims, see p.2, lines 13-16 *; column W *; | [Y]WO9906049 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-5 * see p. 2, line 23, see claims *; column W *; | [YD]WO9724119 (SMITHKLINE BEECHAM CORP [US], et al) [YD] 1-5 * see p. 3, lines 4-6, see claims *; column W *; | [Y]WO9606087 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-5 * see p.2, line 21, see claims *; column W *; | [Y]WO9701540 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-5 * see p. 3, line 10, see claims *; column W *; | [Y]WO9911626 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-5 * see p.3, line 15, see claims *; column W *; | [Y] - ELLISON J A ET AL, "OSTEOPONTIN AND ITS INTEGRIN RECEPTOR ALPHAVBETA3 ARE UPREGULATED DURING FORMATION OF THE GLIAL SCAR AFTER FOCAL STROKE", STROKE, AMERICAN HEART ASSOCIATION, DALLAS TX, US, (199808), vol. 29, no. 8, ISSN 0039-2499, pages 1698 - 1706, XP001029459 [Y] 1-5 * see p.1705, par. bridging left/right col. *; column W * | International search | [T]WO9814192 (SMITHKLINE BEECHAM CORP [US], et al) | [PT] - MILLER ET AL., "Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine gly-asp mimetic", JOURNAL MEDICINAL CHEMISTRY,, (20000113), vol. 43, no. 1, pages 22 - 26, XP002931378 DOI: http://dx.doi.org/10.1021/jm990446u |